A combination of Trastuzumab and 17-AAG induces enhanced ubiquitinylation and lysosomal pathway-dependent ErbB2 degradation and cytotoxicity in ErbB2-overexpressing breast cancer cells.

Srikumar M Raja; Robert J Clubb; Mitra Bhattacharyya; Manjari Dimri; Hao Cheng; Wei Pan; Cesar Ortega-Cava; Alagarsamy Lakku-Reddi; Mayumi Naramura; Vimla Band

doi:10.4161/cbt.7.10.6585

A combination of Trastuzumab and 17-AAG induces enhanced ubiquitinylation and lysosomal pathway-dependent ErbB2 degradation and cytotoxicity in ErbB2-overexpressing breast cancer cells.

Identifier:nobleid.org/w1/20260515/CFD39DDC

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/CFD39DDC.svg?ark=w1%2F20260515%2FCFD39DDC)](https://nobleid.org/work/w1/20260515/CFD39DDC)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Alagarsamy Lakku-Reddi

Mayumi Naramura

Vimla Band

Claim authorship of this work

A combination of Trastuzumab and 17-AAG induces enhanced ubiquitinylation and lysosomal pathway-dependent ErbB2 degradation and cytotoxicity in ErbB2-overexpressing breast cancer cells.

Identifier:nobleid.org/w1/20260515/CFD39DDC

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/CFD39DDC.svg?ark=w1%2F20260515%2FCFD39DDC)](https://nobleid.org/work/w1/20260515/CFD39DDC)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Alagarsamy Lakku-Reddi

Mayumi Naramura

Vimla Band

Claim authorship of this work